Results for “ ”

Entry Author Date Location
Bio Roundup: Sarepta’s Approval, Merck M&A, Drug Price Bill & More 12/13/19 National
In an About-Face, FDA Approves Second Sarepta Muscular Dystrophy Drug 12/13/19 Boston
Iterum’s Antibiotic for Super Bugs Falls Short in Phase 3, Shares Sink 12/11/19 National
Flagship’s Cellarity Aims to Advance Cell Behavior-Based Therapeutics 12/11/19 Boston
KalVista Pharma Eye Drug Partnered With Merck Flunks Phase 2 Test 12/10/19 Boston
Perceptive Unveils New $210M Fund to Invest in Early-Stage Biotechs 12/10/19 New York
Merck Makes a Big Blood Cancer Bet With $2.7B Deal for ArQule 12/09/19 New York
AstraZeneca Taps Gatehouse Bio to Identify Potential Drug Targets 12/09/19 Boston
3 Takeaways From the Resurrection of Biogen’s Alzheimer’s Drug 12/06/19 San Diego
FDA Puts Partial Hold on Tests of Ipsen Drug Acquired in $1B Deal 12/06/19 National
Bio Roundup: Biogen at CTAD, Sage’s Stumble, Astellas’s $3B Offer & More 12/06/19 National
Biogen Points to Enrollment and Dosing to Explain Alzheimer’s Results 12/05/19 National
FDA Rejects Enzyvant’s Regenerative Therapy for Rare Immune Disorder 12/05/19 Boston
Sage Therapeutics Depression Drug Fails in Phase 3, Shares Fall 60% 12/05/19 Boston
As Alzheimer’s Conference Kicks Off, All Eyes Are on Biogen’s Drug 12/05/19 San Diego
Civetta Therapeutics Unveils a Propeller Protein Plan, $53M in Funding 12/04/19 Boston
Caraway Therapeutics Names Martin Williams as CEO 12/03/19 Boston
IFM Lands $55.5M to Launch NewCo Quattro and Discovery Incubator 12/02/19 Boston
La Jolla Pharma’s Share Price Halves On Trial End, CEO Departure 11/26/19 San Diego
Global Blood’s Sickle Cell Drug Wins FDA Approval Ahead of Schedule 11/25/19 San Francisco
Ferring and Blackstone Team Up to Fund Gene Therapy Firm With $570M 11/25/19 Boston
Novartis to Acquire MedCo and FDA-Ready Cholesterol Drug for $9.7B 11/25/19 New York
Bio Roundup: So Long Celgene, RNAi’s Arrival, Pharma in 2020 & More 11/22/19 National
With Cell-By-Cell Take on Drug Discovery, Immunitas Debuts With $39M 11/21/19 Boston
Alnylam Gets Quick FDA OK for Second RNAi Rare Disease Drug 11/20/19 Boston
Liquid Biopsy Firm Lucence Plans Bay Area Buildout With $20M in Tow 11/20/19 San Francisco
Biopharma Execs Remain Optimistic Despite Political Headwinds 11/20/19 National
France-Based Tissium Boosts US Work After Closing €38.75M Series B 11/20/19 Boston
Novo Ventures Commits $25M to Grow Discovery “Greenhouse” in Boston 11/19/19 Boston
With “Inflection Year” Ahead, Ovid Adds Novartis’s Tardio to C-Suite 11/18/19 New York
Page 2 of 376 « previous page · next page »